Oxford Financial Group LTD Castle Biosciences Inc Transaction History

Oxford Financial Group LTD

  • $1.44 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
SELL
$58.92 - $97.33 $317,814 - $524,998
-5,394 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$43.6 - $73.05 $3.55 Million - $5.94 Million
-81,326 Reduced 93.78%
5,394 $362,000
Q2 2020

Aug 05, 2020
BUY
$27.28 - $43.01 $1.88 Million - $2.96 Million
68,924 Added 387.3%
86,720 $3.27 Million
Q1 2020

May 12, 2020
BUY
$23.08 - $35.53 $410,731 - $632,291
17,796 New
17,796 $530,000

Others Institutions Holding CSTL

# of Institutions
162
Shares Held
25.3M
Call Options Held
82.2K
Put Options Held
150K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email